Nano Retina Inc.

Artificial retina for degenerative ophthalmic diseases

Israel’s Nano Retina Inc. is developing an artificial retina that it hopes will provide a superior solution for restoring sight to patients with late-stage AMD and other degenerative ophthalmic diseases, who currently have no curative options. Its permanently implantable device is powered by an eye-safe laser that can be imbedded or attached to eyeglasses.

More from Archive

More from Medtech Insight